Skip to content
value.today

Consano Medical, Inc.

Total raised
$83 M
8 rounds on record
Latest round
$7 M
May 2026
First round on record
May 2014
Today
Private
No later event on record

Funding rounds

8 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Consano Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$7 MNo. 8$2 to $10 million

Consano Medical, Inc.: Raise no. 8, May 2026

Investors in this round

56 investors had bought by the notice of May 29, 2026: 56 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
$1,318
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$650,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Khalid Ghafari · Executive Officer · CFO
  • Rich Keenan · Executive Officer · CPO
  • Todd Dunn · Executive Officer · CEO
  • Christopher Dewey · Director
  • Clay Heighten · Director
  • David Matlin · Director
  • Mark Goldwasser · Director
  • Maurice Ferre · Director
  • Mike Stansky · Director
  • Ram Reddy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in all US states

Remarks in the notice

  • On the use of proceeds: “Ceros receives a 10% commission for sourcing investors and 5% commission for investors introduce by Potrero Medical, Inc.”

Signed by Todd Dunn, Chief Executive Officer. Source: SEC Form D, newest notice filed May 29, 2026. Read the notice at the SEC.

equitySEC
Aug 2025$2 MNo. 7$2 to $10 million

Consano Medical, Inc.: Raise no. 7, Aug 2025

Investors in this round

29 investors had bought by the notice of Sep 2, 2025: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $6 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$500,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rich Keenan · Executive Officer · Chief Product Officer
  • Todd Dunn · Executive Officer, Director · Chief Executive Officer
  • Chad Zaring · Director
  • Christopher Dewey · Director
  • Mark Goldwasser · Director
  • Maurice Ferre · Director
  • Ramachandra Reddy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in all US states

Remarks in the notice

  • On fees: “Ceros receives 10% commission for sourcing investors and 5% commission for investors introduced by Potrero Medical, Inc.”

Signed by Todd Dunn, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 2, 2025. Read the notice at the SEC.

equitySEC
Oct 2024$3 MNo. 6$2 to $10 million

Consano Medical, Inc.: Raise no. 6, Oct 2024

Investors in this round

6 investors had bought by the notice of Oct 31, 2024: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $12 M offered; $9 M still to sell
Smallest investment taken
$50,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,165,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rich Keenan · Executive Officer · Chief Product Officer
  • Sanjay Banerjee · Executive Officer · Chief Executive Officer
  • Christopher Dewey · Director
  • Mark Goldwasser · Director
  • Maurice Ferre · Director
  • Ramachandra Reddy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in all US states

Remarks in the notice

  • On fees: “Ceros receives 10% commission for sourcing investors and 5% commission for investors introduced by Potrero Medical, Inc.”

Signed by Sanjay Banerjee, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 31, 2024. Read the notice at the SEC.

equitySEC
Mar 2023$18 MNo. 5$10 to $50 million

Consano Medical, Inc.: Raise no. 5, Mar 2023

Investors in this round

99 investors had bought by the notice of Apr 10, 2023: 99 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $25 M offered; $7 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$479,996
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joe Urban · Executive Officer, Director
  • Alan Chesler · Director
  • Andrew Offer · Director
  • Colby Wood · Director
  • Daniel Burnett · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ceros Financial Services, Inc. (CRD 37869) · Rockville, MarylandSold in all US states

Signed by Joseph Urban, President and CEO. Source: SEC Form D, newest notice filed Apr 10, 2023. Read the notice at the SEC.

equitySEC
Jun 2019$17 MNo. 4$10 to $50 million

Consano Medical, Inc.: Raise no. 4, Jun 2019

Investors in this round

26 investors had bought by the notice of Oct 29, 2019: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $20 M offered; $3 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Joe H. Urban · Executive Officer, Director
  • Alan Chesler · Director
  • Carter Meyer · Director
  • Daniel Burnett · Director
  • Frederic H. Moll · Director
  • Jay H. Watkins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Urban, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Oct 29, 2019. Read the notice at the SEC.

equitySEC
May 2018$25 MNo. 3$10 to $50 million

Consano Medical, Inc.: Raise no. 3, May 2018

Investors in this round

32 investors had bought by the notice of Jul 10, 2018: 32 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$25 M of $31 M offered; $7 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Burnett · Executive Officer, Director
  • Joe Urban · Executive Officer
  • Alan Chesler · Director
  • Carter Meyer · Director
  • David Greenberg · Director
  • George Rapier · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joseph Urban, President and CEO. Source: SEC Form D, newest notice filed Jul 10, 2018. Read the notice at the SEC.

equitySEC
Aug 2016$7 MNo. 2$2 to $10 million

Consano Medical, Inc.: Raise no. 2, Aug 2016

Investors in this round

21 investors had bought by the notice of Aug 7, 2017: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $12 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Burnett · Executive Officer, Director
  • Alan Chesler · Director
  • Carter Meyer · Director
  • David Greenberg · Director
  • George Rapier · Director
  • Urban Joe · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Burnett, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Aug 7, 2017. Read the notice at the SEC.

equitySEC
May 2014$4 MNo. 1$2 to $10 million

Consano Medical, Inc.: Raise no. 1, May 2014

Investors in this round

9 investors had bought by the notice of May 27, 2014: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$12,500
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$272,999
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Burnett · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Kevin Farrelly (CRD 5181178) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, CaliforniaSold in all US states
  • Andrew Finnegan (CRD 2709048) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, CaliforniaSold in all US states
  • Aaron Travis (CRD 2440803) · broker-dealer Gordian Investments, LLC (CRD 158611) · San Francisco, CaliforniaSold in all US states
  • Ehrenberg Chesler Securities, Inc. (CRD 130790) · broker-dealer Ehrenberg Chesler Securities, Inc. (CRD 108) · San Antonio, TexasSold in all US states

Signed by Daniel Burnett, Ceo. Source: SEC Form D, newest notice filed May 27, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Consano Medical, Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).

    SEC Form D · May 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2026

That is all the official record says: Consano Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Consano Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 8 rounds above had up to 99 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Consano Medical, Inc.
NameRoleNamed in
Khalid GhafariCFOMay 2026
Rich KeenanCPOMay 2026
Todd DunnCEOMay 2026
Sanjay BanerjeeChief Executive OfficerOct 2024
Joe UrbanExecutive officerApr 2023
Joe H. UrbanExecutive officerOct 2019
Daniel BurnettExecutive officerJul 2018
Christopher DeweyDirectorMay 2026
Clay HeightenDirectorMay 2026
David MatlinDirectorMay 2026
Mark GoldwasserDirectorMay 2026
Maurice FerreDirectorMay 2026
Mike StanskyDirectorMay 2026
Ram ReddyDirectorMay 2026
Chad ZaringDirectorSep 2025
Ramachandra ReddyDirectorSep 2025
Todd DunnChief Executive OfficerSep 2025
Alan CheslerDirectorApr 2023
Andrew OfferDirectorApr 2023
Colby WoodDirectorApr 2023
Daniel BurnettDirectorApr 2023
Joe UrbanDirectorApr 2023
Carter MeyerDirectorOct 2019
Frederic H. MollDirectorOct 2019
Jay H. WatkinsDirectorOct 2019
Joe H. UrbanDirectorOct 2019
David GreenbergDirectorJul 2018
George RapierDirectorJul 2018
Urban JoeDirectorAug 2017